Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial

Abstract Aims Although heart failure (HF) with preserved ejection fraction (HFpEF) is a leading cause for hospitalization, its overall costs remain unclear. Therefore, we assessed the health care‐related costs of ambulatory HFpEF patients and the effect of spironolactone. Methods and results The ald...

Full description

Bibliographic Details
Main Authors: Djawid Hashemi, Ludwig Dettmann, Tobias D. Trippel, Volker Holzendorf, Johannes Petutschnigg, Rolf Wachter, Gerd Hasenfuß, Burkert Pieske, Antonia Zapf, Frank Edelmann
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:ESC Heart Failure
Subjects:
Heart failure
Heart failure with preserved ejection fraction
Economic costs
Economics
Online Access:https://doi.org/10.1002/ehf2.12606

Internet

https://doi.org/10.1002/ehf2.12606

Similar Items